PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of bmcphBioMed Centralsearchsubmit a manuscriptregisterthis articleBMC Public Health
 
BMC Public Health. 2012; 12: 350.
Published online May 14, 2012. doi:  10.1186/1471-2458-12-350
PMCID: PMC3413572
Youth in the Netherlands Study (JOiN): study design
Anja C Huizink,corresponding author1 Kirstin Greaves-Lord,2 Brittany E Evans,1,2 Anja S Euser,1,3 Jan van der Ende,2 Frank C Verhulst,2 and Ingmar HA Franken2,3
1VU University, Faculty of Psychology and Education, Department of Developmental Psychology, van der Boechorststraat 1, 1081 BT, Amsterdam, the Netherlands
2Department of Child and Adolescent Psychiatry, Erasmus Medical Center, P.O. Box 2060, 3000 CB, Rotterdam, the Netherlands
3Institute of Psychology, Erasmus University Rotterdam, Woudestein T12-59, P.O. Box 1738, 3000 DR, Rotterdam, the Netherlands
corresponding authorCorresponding author.
Anja C Huizink: a.c.huizink/at/vu.nl; Kirstin Greaves-Lord: k.greaves-lord/at/erasmusmc.nl; Brittany E Evans: b.evans/at/erasmusmc.nl; Anja S Euser: euser/at/fsw.eur.nl; Jan van der Ende: jan.vanderende/at/erasmusmc.nl; Frank C Verhulst: f.verhulst/at/erasmusmc.nl; Ingmar HA Franken: franken/at/fsw.eur.nl
Received March 21, 2012; Accepted May 14, 2012.
Background
Adolescence is a critical developmental period regarding exposure to substances. Therefore, it is important to be able to identify those adolescents who are most vulnerable to substance abuse in the (near) future. The JOiN study was specifically designed to examine two endophenotypes of adolescent substance use in a normal risk (NR) and high risk (HR) sample of adolescents: (1) behavioural disinhibition, and (2) individual differences in stress sensitivity.
Methods
The NR adolescents were part of a longitudinal general population study at the Erasmus Medical Center in Rotterdam, the Netherlands of children and adolescents initially aged 6 to 18 years old. Three assessment waves have been nearly completed, and data are available of N = 711 participants for stress sensitivity measures, and of a subsample of N = 110 for electroencephalography (EEG) measures. Added to this study, HR adolescents who had at least one parent with a substance use disorder and who were treated by an outpatient clinic of a primary addiction care provider were approached via their parent(s). In total, N = 83 adolescents formed this HR sample. NR and HR adolescents participated in standardized stress procedure and EEG procedures in our laboratory. Questionnaires were filled out on background variables, behavioural and emotional problems, and substance use, and a diagnostic interview was conducted with adolescents and parents to assess psychopathology symptoms. DNA was collected through saliva or blood samples.
Discussion
The design of the JOiN study is optimal for examining the predictive role of endophenotypes of adolescent substance use. The combination of different methods, i.e. stress physiology, electrophysiology, genetics, and questionnaire data from several informants on a range of behaviours and environmental factors enables the investigation of the multifactorial nature of adolescent substance use.
Keywords: Adolescent Substance Use, Endophenotypes, EEG, Stress reactivity, Behavioral Disinhibition
Since 1983, the Department of Child and Adolescent Psychiatry in Rotterdam, the Netherlands, has conducted surveys every decade to assess the level of psychiatric problems in children and youth, to test for time-trends in the occurrence of these problems, and to (re)validate the well-known and often used ASEBA instruments in the Netherlands (South Holland study). Numerous publications can be found that describe the findings of these surveys (e.g. [1-5]). As part of that ongoing study, the Youth in the Netherlands (Jongeren Onderzoek in Nederland in Dutch, abbreviated as JOiN) study was initiated. This study selected adolescents from the survey, aged 12 to 20 years, and enriched this sample with high risk (HR) youth, of whom at least one parent was in clinical treatment for a substance use disorder (alcohol or illicit drugs).
Scope of research
Adolescence is a critical developmental period regarding exposure to substances. Therefore, it is important to be able to identify those adolescents who are most vulnerable to substance abuse in the (near) future. Genetic susceptibility is one important factor that underlies individual vulnerability. For complex multifactorial disorders such as substance abuse, the identification of susceptibility genes may be substantially aided by using quantitative intermediate phenotypes, or endophenotypes, instead of dichotomized clinical variables [6]. These endophenotypes reflect neurobiological pathways to substance abuse. The JOiN study was specifically designed to examine several endophenotypes of adolescent substance use. These endophenotypes represent two neurobiological pathways to substance misuse or abuse: (1) behavioural disinhibition, as a possible result of altered cognitive functions of the prefrontal cortex and (2) individual differences in stress sensitivity. Behavioural disinhibition includes two measures: (a) the P300 component of the Event-Related Potential (ERP), which is associated with attentional allocation and context updating processes of working memory and involves the activation of inhibitory processes [7], and (b) risky decision making, or reward-associated decision-making skills, which have been associated with substance abuse in adults. Likewise, individual differences in stress physiological responses are represented by two endophenotypes: measures of stress reactivity of (c) the hypothalamic-pituitary-adrenal (HPA) axis and (d) the autonomic nervous system (ANS). More details on the measures of the endophenotypes and the outcomes are presented in Tables Tables11 and and2,2, respectively.
Table 1
Table 1
Endophenotypes under study
Table 2
Table 2
Main outcomes of the JOiN study assessed at T1 and/or T2
The general aims of the JOiN study are:
(1) to examine the role of endophenotypes, representing two potentially important underlying pathways towards substance abuse, that explain individual resilience and vulnerability to early onset of substance use and the transition to regular use;
(2) to identify, based on the endophenotypes, the most vulnerable group of adolescents with regard to substance misuse and abuse;
(3) to examine the relationship between endophenotypic characteristics and common and specific DNA polymorphisms that have been associated with increased risk for substance abuse in adult populations.
The JOiN study sample consists of a normal risk (NR) sample and a high risk (HR) sample. The NR sample is part of a larger sample that participated in a longitudinal general population study at the Erasmus MC in Rotterdam, the Netherlands of children and adolescents initially aged 6 to 18 years old [21]. For this larger study, 2567 children and adolescents were randomly drawn from municipal registers of 35 representative municipalities in the Dutch province of South Holland including urban and rural areas. Of these 2567 children and adolescents, 2286 were eligible for participation (191 had parents that did not speak Dutch, 31 had a physical or mental disability, 31 were unable to be reached (had missing or faulty contact details), 22 departed the study area, 6 for whom no person could complete questionnaires). Of the 2286 eligible participants, 1710 (74.8%) agreed to participate at the baseline assessment wave (T0), which took place in 2003–2004. Participants did not differ from non-participants at this baseline assessment in terms of gender (p > .05). The next assessment wave (T1) of this sample ran from September 2005 until March 2009. A second follow-up (T2) started in 2009 and is currently nearly completed.
The JOiN study includes a subgroup of participants of this larger study that took part in a stress and electroencephalography (EEG) procedure at T1 (see Figure Figure1),1), which we refer to as the normal risk (NR) sample. Of the 1710 participants at T0, n = 1161(67.9%) participants were eligible to be part of this NR population, the other n = 549 were not selected based on their age (< 11 years old) or lack of permission to be contacted for follow-up research. Of these 1161 eligible individuals, N = 990 (85.3%) participated in T1, of which N = 711 in the stress procedure, and N = 110 in the EEG procedure. For more details on the NR population, please see the section ‘Response’ further down below and Figure Figure11.
Figure 1
Figure 1
Flow chart of participation of thenormal risk(NR) population
We further enriched this NR sample with a high risk (HR) population of adolescents. The HR population of adolescents included participants with a familial risk for substance use disorders. These HR adolescents presumably have an increased risk to show altered endophenotypic characteristics due to their genetic vulnerability for substance use disorders. They all had at least one parent with a substance use disorder (alcohol or illicit drugs), for whom treatment was necessary and provided by Bouman GGZ, the primary addiction care provider in the city of Rotterdam and the surrounding area (Zuid-Holland), and were considered as HR for our study purpose. The parent(s) of these adolescents were recruited from a consecutive series of patients referred to Bouman GGZ in the period of May 2009 – November 2011. For a small number of HR participants (n = 6) of whom the parent had a substance use disorder, the parent was not in treatment, but parent and adolescent were recruited by word of mouth. For these parents, substance use disorder was ascertained with a standardized diagnostic interview (CIDI; [20]) prior to participation of the adolescent in the study. In total, N = 83 HR adolescents were included in the JOiN study. Other inclusion criteria for this HR group of adolescents were similar to those of the NR population. We specifically checked for (severe) mental retardation and epilepsy, which were considered exclusion criteria for EEG measures.
Power of the study
Our sample size was calculated to be at least N = 600 in order to have enough power to run our analyses. For continuously distributed variables (such as number of cigarettes smoked, number of alcoholic beverages consumed), such a sample size yields a power of 0.99 to show a contribution to the explained variance of 5% in a linear regression model with 10 predictors, for main effects and/or interactions (alpha set on 0.05). For categorical outcome variables with a rate of 12%, a sample size of N = 600 yields a power of > 90% to demonstrate a Relative Risk (RR) of 2 (alpha set on 0.05). Because the study has several measurements on behavior and substance use repeated over time, the accuracy of measuring the true underlying value will be increased, which will add to the statistical power for these measurements. Also, the addition of a high risk sample of adolescents will increase the frequency of risk alleles in our total study sample. The program Quanto V was used for genetic power analyses for continuous outcomes (e.g. number of cigarettes smoked). For the estimate of power to detect main effects of genes, we assumed a ‘disorder’ allele frequency of 0.35, which is based on actual allele frequencies of DRD2 and DRD4 SNPs that were genotyped in a Finnish Twin study, very recently (Kaprio, personal communication). For continuous outcomes, the study was estimated to have over 80% power to detect a genetic main effect and a G*E interaction effect that accounts for 10% or more of the total variance.
Study procedure and data collection
The study was approved by the Medical Ethics Committee of the Erasmus Medical Center, the Netherlands, and was conducted in accordance with the declaration of Helsinki. Written informed consent was obtained from all participating adolescents and their parents.
Participants for the NR population were informed about the study through mail sent to their home address, and a subsequent telephone call to invite them to participate in the baseline assessment (T0, [21]). Data for T0 were collected via mailed packages containing questionnaires sent to the participants and their parents. If the participants agreed to participate, but did not return their questionnaires in time, they were reminded through a telephone call from the researchers for several times (maximally 3) if needed. Data from T0 were scanned using Teleform into data-files and were visually checked for missing data or errors by the researchers.
NR adolescent participants at T0 were approached by telephone by our researchers for the T1 assessment and the general goals of the JOiN study were explained. Appointments were made for a visit to (a) the Erasmus Medical Center or a testing facility near to the participants’ home address and (b) the Erasmus Behavioral Lab (Erasmus University Rotterdam) to measure the endophenotypes under study in two experimental sessions. The NR adolescents first participated in a stress procedure, conducted at a laboratory of the Erasmus Medical Center, Department of Child and Adolescent Psychiatry. One hundred and ten of these NR adolescents (native Dutch adolescents, 59 males, ranging from 12 to 20 years old, mean age = 15.26, SD = 2.17) subsequently participated in an EEG procedure at the Erasmus Behavioral Lab (Erasmus University Rotterdam). More details about these EEG procedures are provided below.
The parents of the HR population were informed about the study by the treatment staff of Bouman GGZ. All patients who had a child in the age range of 12–20 years received an information package on the study, and were asked if they approved of their child to participate. If they agreed, the patients and their child were screened by telephone on inclusion and exclusion criteria. If they were found to be eligible, an appointment was made for T1 assessments. 107 families were approached which included at least 131 eligible adolescents. Of these, 83 adolescents from 64 families participated in the study.
Prior to the experimental sessions (see below), questionnaires and four tubes for assessment of salivary cortisol levels on a normal day were sent to the participants by mail. Detailed written instructions were given on the time and manner of sample collections, and to preserve the tubes in the freezer until the testing day. Participants were instructed to provide the first sample directly upon awakening (Cort1), the second 30 minutes afterwards (Cort2), the third at 12 p.m. (Cort3) and the fourth at 8 p.m. (Cort4). Participants then brought the frozen tubes to the session that collected their endophenotypic characteristics, along with questionnaire data on the main outcomes and covariates. The experimental sessions included a stress procedure and an EEG procedure, which together lasted approximately three to four hours.
The stress procedure took place during the afternoon in order to minimize differences in cortisol levels due to normal diurnal variations. The experiment leader explained the procedure before the session started. The electrodes of the electrocardiogram were attached and participants were told to breathe normally and to relax. For the NR population, this procedure started with filling out a questionnaire set, followed by a ten minute pre-task resting period, after which the social stress tasks began. For the HR sample, the questionnaire set was filled out shortly before the EEG procedure, but the stress procedure similarly started with a ten minute pre-task resting period. The stress session ended with a five minute recovery period and a subsequent calm nature documentary that was shown for 25 minutes for further relaxation. After each period/task, during the middle of the movie and at the end of it, the participant was asked to passively drool into a test tube in order to collect salivary cortisol. In total, six test tubes were filled with saliva on the day of the testing session, and heart rate was monitored continuously using a three-lead electrocardiogram throughout the entire stress procedure, which lasted for approximately 90 minutes. Also, blood pressure was monitored continuously, using a Portapress device. All saliva samples were kept in a freezer at −20 degrees Celsius until data collection was complete. All samples were sent to the laboratory (Kirschbaum Laboratory in Dresden, Germany) for analysis. A time-resolved fluorescence immunoassay was used in order to determine the cortisol concentration in the saliva samples. Heart rate data were stored offline to be analyzed at a subsequent moment and were visually checked for artefacts.
The EEG session lasted approximately 75 minutes in total. Participants were seated on a comfortable chair in a light and sound-attenuated room. While filling in a questionnaire set, the EEG electrodes were attached. Hereafter, participants conducted a visual novelty oddball task and a gambling/decision-making paradigm (i.e., the Balloon Analogue Risk Task; BART).
The EEG was recorded with BioSemi Active-Two using 34 scalp sites (10–10 system, and two additional electrodes at FCz and CPz) with Ag/AgCl active electrodes mounted in an elastic cap. Two electrodes were attached to the left and right mastoids as reference electrodes. To be able to correct for ocular artifacts, two electrodes were placed next to each eye for horizontal electrooculogram (HEOG) and two electrodes were placed above and below the left eye for vertical electrooculogram (VEOG). Online signals were recorded with a low-pass filter of 134 Hz. All signals were digitized with a sampling rate of 512 Hz and 24 bit A/D conversion. EEG data were stored offline to be analyzed (using Brain Vision Analyzer 2) at a subsequent moment and then off-line referenced to mathematically linked mastoids, filtered, ocular corrected, baseline corrected, visually checked for artefacts and finally, relevant epochs were averaged for relevant artefact free trials at each scalp site, for each participant. All participants received a gift certificate worth 50 euro for their participation in the experimental session.
Besides questionnaire data and endophenotypic data, DNA was also collected at T1 through saliva or blood samples from the adolescents. Blood and buccal swab samples were stored at −20 degrees Celsius. Saliva samples contained in Oragene containers were stored at room temperature. Genotyping will be conducted by PCR (polymerase chain reaction) in a genetic laboratory.
Furthermore, diagnostic interview data were collected at T1. Parents of the participants who had completed the experimental sessions were contacted by telephone by a research assistant to make an appointment for interviews with the parents as well as the adolescents. The Composite International Diagnostic Interview (CIDI; [20]) pertains to symptoms of psychopathology and was completed by either one or both parents 73.4% (727/990) participated in the interviews, of which 35.2% mother, 5.0% father, 59.8% both). The Diagnostic Interview Schedule for Children (DISC; [19,22]) pertains to symptoms of psychopathology in youth and was completed by one of the parents about their child (parent-report version) and by the participants about themselves (self-report version).
Finally, T2 assessment for the NR and HR adolescents was conducted approximately one year after T1 through mailed packages of questionnaires (see procedure for T0).
Data collection normal risk population only
At baseline (T0, 2003–2004) general demographic information (i.e. gender, age, social-economic status, and ethnicity) was collected from the sample of NR participants of the general population as well as information on behavioural and emotional problems. To obtain a complete view on adolescent’s problem behaviours, information from multiple informants and differences among them is needed [23]. Adolescents’ behavioural and emotional problems were assessed with: Child Behaviour Checklist (CBCL/6-18; parent report); Youth Self-Report (YSR); Teachers’ Report Form (TRF). The content of the above mentioned scale is the same for all three informants, although the scales vary in some items across informants. All items, which are scored 0 (not true), 1 (somewhat or sometimes true) or 2 (very true or often true), are based on the preceding 6 months. Eight syndrome scores are derived: Withdrawn/Depressed, Somatic Complaints, Anxious/Depressed, Social Problems, Thought Problems, Attention Problems, Rule-Breaking Behavior, and Aggressive Behaviour. Good reliability and validity of the instruments have been replicated for the Dutch translation [24-26].
Data collection at T1: normal risk and high risk population
Predictor variables
Genotype
Polymorphisms in several genes related to our endophenotypes and/or our outcome of interest will be determined, including (but not restricted to) the D2/4 (DRD2/DRD4) dopamine receptor gene, the mu-opioid receptor gene (OPRM1), the GABA-a receptor gene (GABRA2), the muscarinic acetylcholine receptor gene (CHRM2), and the Catechol-O-Methyltransferase (COMT) gene.
Endophenotypes
An overview of endophenotypes covered in the JOiN study is provided in Table Table1.1. For the first neurobiological pathway, behavioural disinhibition, several cognitive indices and personality measures were included in our study design. We used a visual novelty oddball paradigm to elicit a P300 ERP response. The amplitude of the P300 has been proposed to reflect attentional allocation, with reduced P300 amplitudes referring to inefficient allocation of attentional resources in processing task-relevant cognitive information (e.g. [8,9]). Furthermore, the automatic response mode version of the Balloon Analogue Risk Task (BART; see [12,27] for further details) was used as an index of reward-associated/risky decision-making skills. In addition, by pairing this measure with EEG recordings, we were also able to investigate the brain’s feedback processing mechanisms during risky decision-making (i.e., the feedback-related negativity (FRN) and the feedback-related P300 amplitude). Moreover, personality traits encompassing three related personality traits of impulsivity, sensation seeking tendencies and sensitivity for reward were assessed, using the I7 questionnaire [15,16], the Brief Sensation Seeking Scale (BSSS; [14]) and BIS/BAS scales [13,28], respectively. The second neurobiological pathway, individual sensitivity to stress, is measured in a standard laboratory setting. Three tasks are used to elicit a physiological stress response of the participants, after baseline measures are collected. Physiological stress responses include cardiovascular reactivity measures (blood pressure, electrocardiogram), and hypothalamic-pituitary-adrenal (HPA) axis response (cortisol). Tasks include (1) a public speaking task, (2) a high speed mathematics task on the computer, and (3) a mental arithmetic task. These tasks have repeatedly been shown to elicit stress responses (e.g. [17,18,29]).
Covariates
General background characteristics were collected on gender, SES, age, weight and height (to determine Body Mass Index), pubertal stage by Tanner [30,31], oral contraceptive use (females only), medication use, birth outcome information reported by the parent(s).
Extensive measures of symptoms of psychopathology were collected in both NR and HR adolescents, including: CBCL, YSR, TRF (see T0), Antisocial Process Screening Device (APSD; [32]); Multidimensional Anxiety Scale for Children (MASC; [33]). In addition, information on temperament was collected with the Emotionality Activity Sociability scale (EAS; [34]). Occurrence of life events were also assessed using a self-report questionnaire developed by the TRAILS consortium [35,36].
Information on family and parental factors included parental substance use (reported by the parent(s)), including information on parental substance use during pregnancy, parenting style as reported by the adolescent and parent (‘My memories of upbringing-Child; EMBU’ [37]) and the ‘Alabama Parenting Questionnaire’; [38]).
Outcome variables
An overview of the most important outcomes for the study aims of the JOiN study is listed in Table Table2.2. To determine symptoms of alcohol, cannabis and other drug abuse and dependence, based on DSM- IV criteria, a highly structured respondent-based interview, the NIMH Diagnostic Interview Schedule for Children (DISC) was applied. Unless otherwise specified, the timeframe of the DISC is the past 12 months. The DISC has two parallel forms: DISC-C administered directly to the adolescent, and DISC-P administered to the parent or parent substitute. Both are used in the present study. The reliability and validity of the DISC have been supported by previous studies [19,22]. Trained and certified students administered the DISC.
To assess age of onset of substance use of adolescents, frequency of substance use, quantity of use, and level of drunkenness or being stoned, a self-reported Substance Use Questionnaire was used, including items on (1) age at first use, (2) (a) monthly, yearly and lifetime prevalence of use, and (b) monthly, yearly, and lifetime prevalence of intensive use (i.e. drunkenness for alcohol users); (3) (a) quantity of alcohol use during the week, and (b) during weekends; (4) (a) number of weekdays and (b) number of weekend days in which alcohol was consumed; (5) the level of drunkenness, and being stoned the last time alcohol or cannabis was consumed, respectively.
Response
Normal risk population
The response rates for the NR sample are illustrated in Figure Figure11 (flowchart). The 990 individuals that took part in T1 did not differ from those who did not (n = 171) with regard to gender or psychopathology, although they did have a slightly higher social economic status (p < .001). The 711 individuals that participated in the stress procedure did not differ from those who did not (n = 990 – 711 = 279) regarding T0 psychopathology, but they did show somewhat more internalizing problems during T1 (p < .05) and more girls participated than boys (p < .01). No differences were found between the 110 individuals that participated in the EEG experiment and those who did not.
High risk population
Estimation of the precise number of eligible adolescents for the HR population, of whom at least one parent was a patient at Bouman GGZ from May 2009 until November 2011 is difficult, because there was no satisfactory registry of the number or age of children of this patient group of Bouman GGZ at the start of our study. Therefore, we did not attempt to identify the overall response rate of this population. However, several remarks regarding the response of this particular subsample can be made. First, when patients at Bouman GGZ were approached by our researchers or by their counsellors to ask for their approval to have their adolescent child contacted by our researchers, we noticed that a large number of patients had limited contact or disturbed relations with their child. This first hurdle reduced the number of available adolescents for our study. Second, if the parent agreed to have their child contacted by our researchers, some of the adolescents themselves did not want to be confronted with the addiction problem of one of their parents, and refused to participate for that reason, or did not have time or motivation to take part in the extensive measures. Third, perhaps because of the adolescent age of our population, if arrangements were made to participate in our study, about half of the adolescents were no-shows at the set time and date for their assessment. Nonetheless, of the 107 approached families, we were able to include n = 83 participants in the HR population.
Limitations
As described in the response section, there was a slight response bias in the NR population with more female, higher socioeconomic status individuals participating. Since children whose parents did not speak Dutch were excluded, the group of ethnic minorities is underrepresented. Moreover, to limit the amount of time spent by the adolescents and their parent(s) in order to maintain feasibility and keep the burden for participants acceptable, we did not include all measures that might, in retrospect, be useful for examining additional hypotheses in our study. For instance, although we included information on several personality characteristics, and on various symptoms of psychopathology, we did not include the whole spectrum of personality that might underlie the occurrence of risk taking behaviour such as substance use. Thus, the breadth of focus may be limited, but the counterbalance is offered by detailed information collected on several occasions on other important factors. Another weakness of the study is that some possibly important determinants of psychopathology that operate earlier in life, such as birth outcomes and prenatal influences, have been assessed retrospectively or not at all.
Strengths
The longitudinal design of the JOiN study, in which a normal risk population of adolescents is combined with a high risk population of adolescents with a familial vulnerability for substance use disorders, is optimal for examining the predictive role of endophenotypes of adolescent substance use.
Furthermore, the combination of different methods, i.e. stress physiology, electrophysiology, genetics, and questionnaire data from several informants on a range of behaviours and environmental factors, in the JOIN study, enables the investigation of the multifactorial nature of adolescent substance use. In addition, the unique element of our study is that various interrelations among endophenotypic characteristics, and between genotype and endophenotype can be tested for their predictive value of substance use. It may therefore contribute to the identification of adolescents at risk for onset of substance use and those who progress to regular use and abuse.
Abbreviations
JOiN: Youth in the Netherlands Study [in Dutch]; NR: Normal risk; HR: High risk; EEG: Electroencephalography; ERP: Event-related potential; HPA axis: Hypothalamic-pituitary-adrenal axis; ANS: Autonomic nervous system; BART: Balloon analogue risk task; T0: Baseline assessment of normal risk population; T1: Assessment of endophenotypes in both normal risk and high risk population; T2: Follow-up assessment one year after T1.
Competing interest
Dr. Verhulst is a contributing author of the Achenbach System of Empirically Based Assessment, from which he receives remuneration. No other competing interests are reported.
ACH conceived of the study, participated in its design and supervised the researchers involved of acquisition of data, acquired the funding, and drafted the manuscript. KGL participated in the coordination of the data-collection and participated in drafting the manuscript. BE and AE substantially contributed to acquisition of data and analysis and interpretation of descriptive data. JvdE and FCV were involved in the conception of the study, participated in its design and critically reviewed drafts of the manuscript. IHAF participated in the conception of the study, contributed to supervision of the researchers involved and critically reviewed drafts of the manuscript. All authors read and approved the final manuscript.
Pre-publication history
The pre-publication history for this paper can be accessed here:
Acknowledgements
The JOiN study is conducted by the Erasmus Medical Center, department of Child and Adolescent Psychiatry, and the Erasmus University, department of Clinical Psychology, in close collaboration with Bouman GGZ. We gratefully acknowledge the contribution of Ben van de Wetering, director of Bouman GGZ and treatment coordinators Jeannette Verveen, Piet Visser, Jannie Wolfert, Bob Pruissers, Daphne Kanner, Peter Tielemans, Peter Lever, and Michiel Boog for their efforts to recruit HR adolescents. The JOIN study is financially supported by ZonMW grant 3116.0002 and ERAB grant 0609. Furthermore, Anja Huizink (PI) and Ingmar Franken were financially supported by NWO-VIDI scheme (452-06-004), and NWO-VIDI scheme (452-07-010), respectively.
  • Reef J, van Meurs I, Verhulst FC, van der Ende J. Children’s problems predict adults’ DSM-IV disorders across 24 years. J Am Acad Child Adolesc Psychiatry. 2010;49:1117–1124. [PubMed]
  • Bongers IL, Koot HM, van der Ende J, Verhulst FC. The normative development of child and adolescent problem behavior. J Abnorm Psychol. 2003;112:179–192. [PubMed]
  • Roza SJ, Hofstra MB, van der Ende J, Verhulst FC. Stable prediction of mood and anxiety disorders based on behavioral and emotional problems in childhood: a 14-year follow-up during childhood, adolescence, and young adulthood. Am J Psychiatry. 2003;160:2116–2121. doi: 10.1176/appi.ajp.160.12.2116. [PubMed] [Cross Ref]
  • Hofstra MB, Van der Ende J, Verhulst FC. Continuity and change of psychopathology from childhood into adulthood: a 14-year follow-up study. J Am Acad Child Adolesc Psychiatry. 2000;39:850–858. doi: 10.1097/00004583-200007000-00013. [PubMed] [Cross Ref]
  • Verhulst FC, Koot HM, Van der Ende J. Differential predictive value of parents’ and teachers’ reports of children’s problem behaviors: a longitudinal study. J Abnorm Child Psychol. 1994;22:531–546. doi: 10.1007/BF02168936. [PubMed] [Cross Ref]
  • Gottesman II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry. 2003;160:636–645. doi: 10.1176/appi.ajp.160.4.636. [PubMed] [Cross Ref]
  • Frederick JA, Iacono WG. Beyond the DSM: defining endophenotypes for genetic studies of substance abuse. Curr Psychiatry Rep. 2006;8:144–150. doi: 10.1007/s11920-006-0014-2. [PubMed] [Cross Ref]
  • Polich J, Pollock VE, Bloom FE. Meta-analysis of P300 amplitude from males at risk for alcoholism. Psychol Bull. 1994;115:55–73. [PubMed]
  • Euser A, Arends LR, Evans BE, Greaves-Lord K, Huizink AC, Franken IHA. The P300 event-related brain potential as a neurobiological endophenotype for substance use disorders: A meta-analytic investigation. Neurosci Biobehav Rev. 2012;36:572–603. doi: 10.1016/j.neubiorev.2011.09.002. [PubMed] [Cross Ref]
  • Polich J, Kok A. Cognitive and biological determinants of P300: an integrative review. Biol Psychol. 1995;41:103–146. doi: 10.1016/0301-0511(95)05130-9. [PubMed] [Cross Ref]
  • Lejuez CW, Read JP, Kahler CW, Richards JB, Ramsey SE, Stuart GL. et al. Evaluation of a behavioral measure of risk taking: the Balloon Analogue Risk Task (BART) J Exp Psychol Appl. 2002;8:75–84. [PubMed]
  • Pleskac TJ, Wallsten TS, Wang P, Lejuez CW. Development of an automatic response mode to improve the clinical utility of sequential risk-taking tasks. Exp Clin Psychopharmacol. 2008;16:555–564. [PubMed]
  • Carver CS, White TL. Behavioral inhibition, behavioral activation, and affective responses to impending reward and punishment: The BIS/BAS scales. JPSP. 1994;67:319–333.
  • Hoyle RH, Stephenson MT, Palmgreen P, Pugzles Lorch E, Donohew RL. Reliability and validity of a brief measure of sensation seeking. Pers Indiv Diff. 2002;32:401–414. doi: 10.1016/S0191-8869(01)00032-0. [Cross Ref]
  • Eysenck S, Pearson PR, Easting G, Allsopp JF. Age norms for impulsiveness, venturesomeness and empathy in adults. Pers Indiv Diff. 1985;6:613–619. doi: 10.1016/0191-8869(85)90011-X. [Cross Ref]
  • Lijffijt M, Caci H, Kenemans JL. Validation of the Dutch translation of the I7 questionnaire. Pers Indiv Diff. 2005;38:1123–1133. doi: 10.1016/j.paid.2004.07.010. [Cross Ref]
  • Childs E, Vicini LM, De Wit H. Responses to the Trier Social Stress Test (TSST) in single versus grouped participants. Psychophysiology. 2006;43:366–371. doi: 10.1111/j.1469-8986.2006.00414.x. [PubMed] [Cross Ref]
  • Kudielka BM, Buske-Kirschbaum A, Hellhammer DH, Kirschbaum C. HPA axis responses to laboratory psychosocial stress in healthy elderly adults, younger adults, and children: impact of age and gender. PNEC. 2004;29:83–98. [PubMed]
  • Verhulst FC, van der Ende J, Ferdinand RF, Kasius MC. The prevalence of DSM-III-R diagnoses in a national sample of Dutch adolescents. Arch Gen Psychiatry. 1997;54:329–336. doi: 10.1001/archpsyc.1997.01830160049008. [PubMed] [Cross Ref]
  • Robins LN, Wing J, Wittchen H-U, Helzer JE, Babor TF, Burke J, Farmer A, Jablensky A, Pickens R, Regier DA, Sartorius N, Towle LH. The Composite International Diagnostic Interview: An epidemiologic instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Arch Gen Psychiatry. 1989;45:1069–1077. [PubMed]
  • Tick NT, van der Ende J, Verhulst FC. Twenty-year trends in emotional and behavioral problems in Dutch children in a changing society. Acta Psychiatr Scand. 2007;116:473–482. doi: 10.1111/j.1600-0447.2007.01068.x. [PubMed] [Cross Ref]
  • Fisher P, Parra MT, Wicks J, Reyland S, Shaffer D. Diagnostic Interview Schedule for Children (NIMH DISC, Version 2.3) New York State Psychiatric Institute, Division of Child and Adolescent Psychiatry, New York; 1992.
  • van der Ende J, Verhulst FC. Informant, gender and age differences in ratings of adolescent problem behaviour. Eur Child Adolesc Psychiatry. 2005;14:117–126. doi: 10.1007/s00787-005-0438-y. [PubMed] [Cross Ref]
  • Verhulst FC, van der Ende J, Koot HM. Nederlandse Handleiding voor de CBCL/4-18 [Manual for the CBCL.4-18 in Dutch] Afdeling Kinder- en jeugdpsychiatrie, Erasmus MC, Rotterdam; 1996.
  • Verhulst FC, van der Ende J, Koot HM. Nederlandse Handleiding voor de TRF [Manual for the TRF in Dutch] Afdeling Kinder- en jeugdpsychiatrie, Erasmus MC, Rotterdam; 1997.
  • Verhulst FC, van der Ende J, Koot HM. Nederlandse Handleiding voor de YSR [Manual for the YSR in Dutch] Afdeling Kinder- en jeugdpsychiatrie, Erasmus MC, Rotterdam; 1997.
  • Euser AS, van Meel CS, Snelleman M, Franken IH. Acute effects of alcohol on feedback processing and outcome evaluation during risky decision-making: an ERP study. Psychopharmacology (Berl) 2011;217:111–125. doi: 10.1007/s00213-011-2264-x. [PMC free article] [PubMed] [Cross Ref]
  • Franken IHA, Muris PEHM, Rassin EGC. Psychometric properties of the Dutch BIS/BAS Scales. J Psychopath Behav. 2005;27:25–30. doi: 10.1007/s10862-005-3262-2. [Cross Ref]
  • Evans BE, Greaves-Lord K, Euser AS, Franken IH, Huizink AC. The relation between hypothalamic-pituitary-adrenal (HPA) axis activity and age of onset of alcohol use. Addiction. 2012;107:312–322. doi: 10.1111/j.1360-0443.2011.03568.x. [PubMed] [Cross Ref]
  • Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child. 1969;44:291–303. doi: 10.1136/adc.44.235.291. [PMC free article] [PubMed] [Cross Ref]
  • Marshall WA, Tanner JM. Variations in pattern of pubertal changes in boys. Arch Dis Child. 1970;45:13–23. doi: 10.1136/adc.45.239.13. [PMC free article] [PubMed] [Cross Ref]
  • Frick PJ, Hare RD. The Antisocial Process Screening Device. Multi-Health Systems, Toronto, Canada; 2001.
  • March JS. Multidimensional Anxiety Scale for Children. Multi- Health Systems-Inc, Toronto, Canada; 1997.
  • Buss AH, Plomin R. Temperament: Early developing personality traits. Erlbaum, Hillsdale, New Jersey; 1984.
  • Amone-P’Olak K, Ormel J, Huisman M, Verhulst FC, Oldehinkel AJ, Burger H. Life stressors as mediators of the relation between socioeconomic position and mental health problems in early adolescence: the TRAILS study. J Am Acad Child Adolesc Psychiatry. 2009;48:1031–1038. doi: 10.1097/CHI.0b013e3181b39595. [PubMed] [Cross Ref]
  • Bosch NM, Riese H, Ormel J, Verhulst F, Oldehinkel AJ. Stressful life events and depressive symptoms in young adolescents: Modulation by respiratory sinus arrhythmia? The TRAILS study. Biol Psychol. 2009;81:40–47. doi: 10.1016/j.biopsycho.2009.01.005. [PubMed] [Cross Ref]
  • Markus MT, Lindhout IE, Boer F, Hoogendijk THG, Arrindell WA. Factors of perceived parental rearing styles: the EMBU-C examined in a sample of Dutch primary school children. Pers Indiv Diff. 2003;34:503–519. doi: 10.1016/S0191-8869(02)00090-9. [Cross Ref]
  • Frick PJ. The Alabama Parenting Questionnaire. Unpublished rating scale. Department of Psychology, University of New Orleans; 1991.
Articles from BMC Public Health are provided here courtesy of
BioMed Central